Compliance Rate
Compliance Rate
20.0%
Compliant submissions
2
Incompliant submissions
8
Total trials
10
My Organizations' Clinical Trials
Showing 200 of 1573 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 05/31/14
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 01/01/15
End: 09/30/19
Due: 09/30/20
Phase: N/A
Priority: Normal
Start: 07/01/17
End: 02/01/19
Due: 02/01/20
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 09/30/17
Due: 09/30/18
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 08/31/14
End: 10/31/14
Due: 10/31/15
Phase: N/A
Priority: Normal
Start: 09/30/01
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: 03/19/25
End: 08/31/28
Due: 08/31/29
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 12/15/25
Due: 12/15/26
Phase: N/A
Priority: Normal
Start: 01/15/18
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 10/01/19
End: 10/14/24
Due: 10/14/25
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 01/31/10
Due: 01/31/11
Factors Influencing Tamoxifen Adherence in Women With Breast Cancer Receiving Tamoxifen in Botswana.
Phase: N/A
Priority: Normal
Start: 03/01/24
End: 12/20/26
Due: 12/20/27
Phase: N/A
Priority: Normal
Start: 03/25/19
End: 07/30/23
Due: 07/30/24
Phase: N/A
Priority: Normal
Start: 02/24/20
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 07/13/20
End: 03/10/22
Due: 03/10/23
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 08/18/21
End: 06/30/25
Due: 06/30/26